EUVIMEDEUVIMED entdecken
Open Access

Acquired hypothalamic obesity: A clinical overview and update

Christian L Roth iD, Shana E McCormack

Diabetes, Obesity and Metabolism · 2024-04 · 26 (S2) · 34-45

DOI: 10.1111/dom.15530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 07.03.2024. Verfasst von Christian L Roth und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, DC, USA. Hauptthemen laut MEDLINE: Hypothalamic Diseases, Craniopharyngioma, Pituitary Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypothalamic obesity (HO) is a rare and complex disorder that confers substantial morbidity and excess mortality. HO is a unique subtype of obesity characterized by impairment in the key brain pathways that regulate energy intake and expenditure, autonomic nervous system function, and peripheral hormonal signalling. HO often occurs in the context of hypothalamic syndrome, a constellation of symptoms that follow from disruption of hypothalamic functions, for example, temperature regulation, sleep–wake circadian control, and energy balance. Genetic forms of HO, including the monogenic obesity syndromes, often impact central leptin–melanocortin pathways. Acquired forms of HO occur as a result of tumours impacting the hypothalamus, such as craniopharyngioma, surgery or radiation to treat those tumours, or other forms of hypothalamic damage, such as brain injury impacting the region. Risk for severe obesity following hypothalamic injury is increased with larger extent of hypothalamic damage or lesions that contain the medial and posterior hypothalamic nuclei that support melanocortin signalling pathways. Structural damage in these hypothalamic nuclei often leads to hyperphagia, central insulin and leptin resistance, decreased sympathetic activity, low energy expenditure, and increased energy storage in adipose tissue, the collective effect of which is rapid weight gain. Individuals with hyperphagia are perpetually hungry. They do not experience fullness at the end of a meal, nor do they feel satiated after meals, leading them to consume larger and more frequent meals. To date, most efforts to treat HO have been disappointing and met with limited, if any, long‐term success. However, new treatments based on the distinct pathophysiology of disturbed energy homeostasis in acquired HO may hold promise for the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypothalamic DiseasesCraniopharyngiomaPituitary NeoplasmsHumansLeptinObesityHypothalamusHyperphagiaMelanocortinsEnergy Metabolism

Stichwörter der Autor:innen

craniopharyngiomaenergy balancehypothalamic obesityinflammationmelanocortinmelanocortin‐4 receptormetabolismneuroimagingpharmacological interventionspre‐clinical modelsrisk factorssetmelanotide

Substanzen

LeptinMelanocortins

Autor:innen und Institutionen

  • Centre for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington, DC, USA.
  • Department of Paediatrics, University of Washington, School of Medicine, Seattle, Washington, DC, USA.
  • Neuroendocrine Centre, Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Paediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Christian L Roth

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Roth, C. L., & McCormack, S. E. (2024). Acquired hypothalamic obesity: A clinical overview and update. Diabetes, Obesity and Metabolism, 26(S2), 34-45. https://doi.org/10.1111/dom.15530

Vancouver

Roth CL, McCormack SE. Acquired hypothalamic obesity: A clinical overview and update. Diabetes, Obesity and Metabolism. 2024;26(S2):34-45. doi:10.1111/dom.15530

BibTeX
@article{Roth2024,
  author = {Roth, Christian L and McCormack, Shana E},
  title = {Acquired hypothalamic obesity: A clinical overview and update},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {S2},
  pages = {34--45},
  doi = {10.1111/dom.15530}
}
Kostenlos starten →